Daiichi Sankyo

Daiichi Sankyo douses a report about an AstraZeneca buyout offer
Daiichi Sankyo douses a report about an AstraZeneca buyout offer
Endpoints
AstraZeneca
Daiichi Sankyo
M&A
Flag link:
Daiichi Sankyo punts $650M collaboration pact as Charleston Labs preps a comeback attempt on spurned pain drug
Daiichi Sankyo punts $650M collaboration pact as Charleston Labs preps a comeback attempt on spurned pain drug
Endpoints
Daiichi Sankyo
Charleston Laboratories
CL-108
painkillers
Flag link:
Daiichi Sankyo hands off cancer drug to Boston Pharma
Daiichi Sankyo hands off cancer drug to Boston Pharma
BioPharma Dive
Boston Pharmaceuticals
Daiichi Sankyo
DS-5010
cancer
Flag link:
Daiichi Sankyo settles U.S. lawsuits over blood pressure drug Benicar
Daiichi Sankyo settles U.S. lawsuits over blood pressure drug Benicar
Reuters
Daiichi Sankyo
Benicar
Flag link:
EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda
EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda
RAPS.org
EMA
Europe
Pfizer
Bavencio
Novartis
Rydapt
Lexicon Pharmaceuticals
Xermelo
Vanda
Fanaptum
Nektar
Onzeald
Daiichi Sankyo
Flag link:
Nektar’s pitch on early cancer drug OK runs into a regulatory brick wall
Nektar’s pitch on early cancer drug OK runs into a regulatory brick wall
Endpoints
Nektar
regulatory
Onzeald
Europe
Daiichi Sankyo
Flag link:
In latest setback, another Coherus partner bails out on Amgen biosimilar deal
In latest setback, another Coherus partner bails out on Amgen biosimilar deal
Endpoints
Coherus
Amgen
biosimilars
Daiichi Sankyo
CHS-0214
rheumatoid arthritis
Enbrel
Flag link:
Daiichi Sankyo sweeps out Pieris drug, 5 others in a Q1 pipeline cleanup
Daiichi Sankyo sweeps out Pieris drug, 5 others in a Q1 pipeline cleanup
Endpoints
Daiichi Sankyo
Pieris
DS-9001
tivantinib
Arqule
Flag link:
Daiichi Sankyo to invest $135M in ADC manufacturing expansion
Daiichi Sankyo to invest $135M in ADC manufacturing expansion
BioPharma Dive
Daiichi Sankyo
drug manufacturing
antibody-drug conjugate
Flag link:
Daiichi, ArQule cancer drug fails in late-stage study
Daiichi, ArQule cancer drug fails in late-stage study
BioPharma Dive
Daiichi Sankyo
Arqule
clinical trials
tivantinib
liver cancer
Flag link:
Daiichi shutters Japanese plant amid restructuring efforts
Daiichi shutters Japanese plant amid restructuring efforts
BioPharma Dive
Daiichi Sankyo
Japan
restructuring
Flag link:
Daiichi Sankyo shutters another R&D center in an ongoing global overhaul
Daiichi Sankyo shutters another R&D center in an ongoing global overhaul
Endpoints
Daiichi Sankyo
R&D
restructuring
Flag link:
Kite Pharma partners with Japan's Daiichi for cancer therapy
Kite Pharma partners with Japan's Daiichi for cancer therapy
Yahoo/Reuters
Kite Pharma
Japan
Daiichi Sankyo
axicabtagene ciloleucel
CAR-T
Flag link:
Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Yahoo
Amgen
Daiichi Sankyo
Japan
biosimilars
Flag link:
Daiichi Sankyo halts late-stage study of lung cancer drug
Daiichi Sankyo halts late-stage study of lung cancer drug
BioPharma Dive
Daiichi Sankyo
clinical trials
non-small cell lung cancer
patritumab
Flag link:
Daiichi Sankyo moves further to cut legacy Ranbaxy ties
Daiichi Sankyo moves further to cut legacy Ranbaxy ties
Fierce Pharma
Daiichi Sankyo
Ranbaxy
Flag link:
Daiichi snaps up Japanese rights to CVD stem-cell therapy
Daiichi snaps up Japanese rights to CVD stem-cell therapy
BioPharma Dive
Daiichi Sankyo
Japan
stem cells
Heartcel
Cell Therapy Group
Flag link:
Vermont governor slams AZ & Daiichi's OIC Super Bowl ad, calls for it to be pulled
Vermont governor slams AZ & Daiichi's OIC Super Bowl ad, calls for it to be pulled
BioPharma Dive
Vermont
AstraZeneca
Daiichi Sankyo
OIC
drug ads
Flag link:
Daiichi Sankyo shuts down a German R&D shop
Daiichi Sankyo shuts down a German R&D shop
Fierce Biotech
Daiichi Sankyo
Germany
R&D
Flag link:
Struggling Daiichi plots another 1,000-plus job cuts in U.S.
Struggling Daiichi plots another 1,000-plus job cuts in U.S.
Fierce Pharma
Daiichi Sankyo
layoffs
Flag link: